1. |
El Oakley RM, Wright JE. Postoperative mediastinitis: Classification and management. Ann Thorac Surg, 1996, 61(3): 1030-1036.
|
2. |
Dubert M, Pourbaix A, Alkhoder S, et al. Sternal wound infection after cardiac surgery: Management and outcome. PLoS One, 2015, 10(9): e0139122.
|
3. |
Lazar HL, Salm TV, Engelman R, et al. Prevention and management of sternal wound infections. J Thorac Cardiovasc Surg, 2016, 152(4): 962-972.
|
4. |
Sugumar H, Lancefield TF, Andrianopoulos N, et al. Impact of renal function in patients with multi-vessel coronary disease on long-term mortality following coronary artery bypass grafting compared with percutaneous coronary intervention. Int J Cardiol, 2014, 172(2): 442-449.
|
5. |
Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet, 1996, 347(9003): 757-758.
|
6. |
Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med, 1986, 314(1): 1-6.
|
7. |
Gao C, Yang M, Wu Y, et al. Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent placement. Ann Thorac Surg, 2009, 87(3): 737-741.
|
8. |
Yang M, Wu Y, Wang G, et al. Robotic total arterial off-pump coronary artery bypass grafting: Seven-year single-center experience and long-term follow-up of graft patency. Ann Thorac Surg, 2015, 100(4): 1367-1373.
|
9. |
Edmunds LH. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg, 1998, 66(5 Suppl): S12-16.
|
10. |
Kikuchi K, Mori M. Less-invasive coronary artery bypass grafting international landscape and progress. Curr Opin Cardiol, 2017, 32(6): 715-721.
|
11. |
Zhao DF, Edelman JJ, Seco M, et al. Coronary artery bypass grafting with and without manipulation of the ascending aorta: A network meta-analysis. J Am Coll Cardiol, 2017, 69(8): 924-936.
|
12. |
Keeling WB, Kilgo PD, Puskas JD, et al. Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index. J Thorac Cardiovasc Surg, 2013, 146(6): 1442-1448.
|
13. |
Altarabsheh SE, Deo SV, Rababa'h AM, et al. Off-pump coronary artery bypass reduces early stroke in octogenarians: A meta-analysis of 18, 000 patients. Ann Thorac Surg, 2015, 99(5): 1568-1575.
|
14. |
Hannan EL, Wu C, Smith CR, et al. Off-pump versus on-pump coronary artery bypass graft surgery: Differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation, 2007, 116(10): 1145-1152.
|
15. |
Börgermann J, Hakim K, Renner A, et al. Clampless off-pump versus conventional coronary artery revascularization: A propensity score analysis of 788 patients. Circulation, 2012, 126(11 Suppl 1): S176-S182.
|
16. |
Dong L, Kang YK, An XG. Short-term and mid-term clinical outcomes following hybrid coronary revascularization versus off-pump coronary artery bypass: A meta-analysis. Arq Bras Cardiol, 2018, 110(4): 321-330.
|
17. |
Harskamp RE, Bagai A, Halkos ME, et al. Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: A meta-analysis of 1, 190 patients. Am Heart J, 2014, 167(4): 585-592.
|
18. |
Zhou S, Fang Z, Xiong H, et al. Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: A comparison study with off-pump coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg, 2014, 147(5): 1511-1516.
|
19. |
Harskamp RE, Abdelsalam M, Lopes RD, et al. Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery. Interact Cardiovasc Thorac Surg, 2014, 19(6): 1008-1012.
|
20. |
Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): A prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet, 2017, 389(10076): 1312-1322.
|
21. |
Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial. Eur Heart J, 2014, 35(40): 2821-2830.
|
22. |
Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data. Lancet, 2018, 391(10124): 939-948.
|
23. |
Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med, 2015, 372(13): 1213-1222.
|
24. |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J, 2019, 40(2): 87-165.
|
25. |
Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013, 61(25): 2525-2533.
|